Transgenic animals are produced through microinjection of DNA into fertilized eggs or embryonic stem cells. The document outlines various methods for producing transgenic animals, including DNA microinjection into pronuclei, retrovirus-mediated gene transfer, and embryonic stem cell-mediated gene transfer. It also describes techniques for identifying transgenic animals, such as PCR and Southern blotting. Examples given of transgenic animals include Dolly the sheep and supermice.
Rishabh Maheshwari presents information on transgenic techniques. Transgenics involve introducing foreign DNA into a host organism's genome, typically using a mouse as the host. This allows for engineering organisms with DNA from another source as part of their genetic material. Common methods to create transgenic animals include DNA microinjection, retrovirus-mediated gene transfer, sperm-mediated gene transfer, and embryonic stem cell-mediated gene transfer. Transgenic technology has applications in disease models, pharmaceutical production, agriculture, and industry. While it has benefits, there are also concerns regarding animal welfare and environmental impacts.
This document discusses various methods for transferring genes into animal cells, including viral and non-viral approaches. Viral methods use viruses like adenovirus to transfer genes, while non-viral methods include biochemical techniques like calcium phosphate transfection, lipid-mediated transfection using lipofectamine, and physical methods like microinjection, particle bombardment/gene guns, ultrasound, and electroporation. The document provides detailed protocols for lipid-mediated transfection and some of the other non-viral methods.
Introduction
History
Landmarks Events in Transgenic Livestock Research
Techniques/ Method for Gene Transfer
Examples of transgenesis
Importance
Application
Limitation
Issue related to Transgenic Technology
Ethical concerns and how to Overcome
Transgenesis involves introducing foreign DNA into an animal's genome. This allows for the production of transgenic animals that exhibit new traits. Common methods for creating transgenic animals include pronuclear microinjection, embryonic stem cell manipulation, and retrovirus-mediated gene transfer. Examples of transgenic animals include glowing fish, disease models like Alzheimer's mice, and farm animals engineered for increased wool/milk. While transgenic technology has benefits for research, agriculture, and medicine, it also carries some risks that require further study.
Ethical issues related to transgenic animalsmahathiviji
This document discusses the ethical issues related to transgenic animals. It begins by defining ethics, bioethics, and the two types of genetic modification - altering genes normally present or transferring genes between individuals. Genetic modification of animals is used to help research human diseases, develop new drugs, provide transplant tissues/organs, and enhance livestock. However, this raises ethical concerns like unpredictable ecosystem impacts, animal welfare issues, risks to human and environmental health, "playing God", and religious concerns over gene transfers between species. The document also discusses regulation bodies like GEAC and issues around patents and biopiracy of genetically modified organisms.
Livestock sector is an important sector in indian economy. To boost the productive performance of existing livestock population in india, biotechnolgy plays a key role to fullfill this.
This document discusses various applications of animal biotechnology. It outlines how transgenic animals can be used to improve biomass production, disease resistance, recombinant vaccine development, and production of pharmaceutical proteins. Specifically, it mentions that transgenic salmon can grow up to 6 times faster than wild salmon due to a growth hormone gene insertion. It also provides examples of using transgenic cattle and goats to produce therapeutic proteins in their milk for human disease treatments.
Gene transfer methods in animals can be natural or artificial. Natural methods include conjugation, transformation, and transduction which transfer genes between bacteria. Artificial methods like microinjection, biolistics, liposome mediated transfer, calcium phosphate mediated transfer, and electroporation are used to directly insert genes into cells. These techniques transfer genes into organisms for genetic engineering applications such as producing transgenic animals, developing vaccines, and gene therapy to treat diseases.
Rishabh Maheshwari presents information on transgenic techniques. Transgenics involve introducing foreign DNA into a host organism's genome, typically using a mouse as the host. This allows for engineering organisms with DNA from another source as part of their genetic material. Common methods to create transgenic animals include DNA microinjection, retrovirus-mediated gene transfer, sperm-mediated gene transfer, and embryonic stem cell-mediated gene transfer. Transgenic technology has applications in disease models, pharmaceutical production, agriculture, and industry. While it has benefits, there are also concerns regarding animal welfare and environmental impacts.
This document discusses various methods for transferring genes into animal cells, including viral and non-viral approaches. Viral methods use viruses like adenovirus to transfer genes, while non-viral methods include biochemical techniques like calcium phosphate transfection, lipid-mediated transfection using lipofectamine, and physical methods like microinjection, particle bombardment/gene guns, ultrasound, and electroporation. The document provides detailed protocols for lipid-mediated transfection and some of the other non-viral methods.
Introduction
History
Landmarks Events in Transgenic Livestock Research
Techniques/ Method for Gene Transfer
Examples of transgenesis
Importance
Application
Limitation
Issue related to Transgenic Technology
Ethical concerns and how to Overcome
Transgenesis involves introducing foreign DNA into an animal's genome. This allows for the production of transgenic animals that exhibit new traits. Common methods for creating transgenic animals include pronuclear microinjection, embryonic stem cell manipulation, and retrovirus-mediated gene transfer. Examples of transgenic animals include glowing fish, disease models like Alzheimer's mice, and farm animals engineered for increased wool/milk. While transgenic technology has benefits for research, agriculture, and medicine, it also carries some risks that require further study.
Ethical issues related to transgenic animalsmahathiviji
This document discusses the ethical issues related to transgenic animals. It begins by defining ethics, bioethics, and the two types of genetic modification - altering genes normally present or transferring genes between individuals. Genetic modification of animals is used to help research human diseases, develop new drugs, provide transplant tissues/organs, and enhance livestock. However, this raises ethical concerns like unpredictable ecosystem impacts, animal welfare issues, risks to human and environmental health, "playing God", and religious concerns over gene transfers between species. The document also discusses regulation bodies like GEAC and issues around patents and biopiracy of genetically modified organisms.
Livestock sector is an important sector in indian economy. To boost the productive performance of existing livestock population in india, biotechnolgy plays a key role to fullfill this.
This document discusses various applications of animal biotechnology. It outlines how transgenic animals can be used to improve biomass production, disease resistance, recombinant vaccine development, and production of pharmaceutical proteins. Specifically, it mentions that transgenic salmon can grow up to 6 times faster than wild salmon due to a growth hormone gene insertion. It also provides examples of using transgenic cattle and goats to produce therapeutic proteins in their milk for human disease treatments.
Gene transfer methods in animals can be natural or artificial. Natural methods include conjugation, transformation, and transduction which transfer genes between bacteria. Artificial methods like microinjection, biolistics, liposome mediated transfer, calcium phosphate mediated transfer, and electroporation are used to directly insert genes into cells. These techniques transfer genes into organisms for genetic engineering applications such as producing transgenic animals, developing vaccines, and gene therapy to treat diseases.
1) The document discusses various cloning technologies including mammalian cloning, reproductive cloning, gene cloning, and therapeutic cloning.
2) Gene cloning involves locating and copying a gene of interest from an organism's DNA. Therapeutic cloning aims to produce patient-matched cells for transplantation through somatic cell nuclear transfer.
3) The benefits of therapeutic cloning discussed include potential alternatives for organ transplantation and treatment of diseases like leukemia and genetic disorders. However, using embryonic stem cells from aborted fetuses is considered morally problematic by some.
Transgenesis is the process of introducing an exogenous gene into an organism to produce a new trait. It allows for more specific, faster, and flexible introduction of traits compared to selective breeding. Golden rice was developed using transgenesis to introduce beta-carotene genes into rice, providing vitamin A. While this could help address vitamin A deficiency, there are also risks like gene transfer and unintended effects that require careful evaluation.
Transfection involves introducing foreign DNA into host cells to produce a new phenotype. There are two main methods of transfection - vector-mediated and non-vector mediated. Vector-mediated transfection uses bacteriophage, retroviral, cosmid, baculovirus, and plasmid vectors to introduce DNA. Non-vector mediated methods include direct techniques like microinjection, electroporation, and particle bombardment, and indirect techniques like calcium phosphate precipitation and DEAE-dextran. Retroviral vectors are modified retroviruses that can introduce foreign DNA into host chromosomal DNA. Microinjection involves injecting DNA directly into cells using a micropipette under a microscope. Electroporation uses electric pulses to create temporary
Types of animal cell culture, characterization and preservationSantosh Kumar Sahoo
Animal cell culture involves growing cells outside their natural environment under controlled conditions. There are two main types of cell culture: primary cell culture which uses cells directly from an animal, and secondary cell culture which uses cell lines that can be propagated repeatedly. Cells may be adherent, attaching to culture surfaces, or in suspension. Characterization of cell lines assesses identity, purity and suitability for use. Cryopreservation allows long-term storage of cells by freezing them at very low temperatures.
Transgenic animals are animals that have had a foreign gene deliberately inserted into their genome using recombinant DNA methodology. The first transgenic mice were created in 1980, and the first cloned mammal, Dolly the sheep, was born in 1996. There are three main methods for creating transgenic animals: DNA microinjection, embryonic stem cell-mediated gene transfer, and retrovirus-mediated gene transfer. Transgenic animals produce useful products like monoclonal antibodies, blood clotting factors, and human milk proteins. They are used for medical research, toxicology studies, pharmaceutical production, and analyzing gene expression regulation. However, some ethical concerns exist regarding animal suffering during transgenic research experiments.
Introduction
Primary Culture
Steps In Primary Culture
Isolation Of Tissue
Dissection And/Or Disaggregation
Types Of Primary Culture
Primary Explant Culture
Enzymatic Disaggregation
Mechanical Disaggregation
Cell Line( Finite & Continuous)
Naming A Cell Line
Choosing A Cell Line
Maintenance Of Cell Line
Conclusion
reference
This is about methods of creating transgenic animals,applications of transgenic animals in biotechnology and application of transgenic animals in pharmaceuticals.
1. Biopharming involves the production of therapeutic proteins through transgenic animals and offers advantages over conventional production methods like lower costs, higher yields, and proper post-translational modifications.
2. The mammary gland is often used for expression since milk can be easily collected and purified. Therapeutic proteins are commonly expressed at grams per liter of milk.
3. While biopharming has promise, challenges remain around low success rates, animal health issues, and concerns about transgene escape into the environment. Ongoing work aims to improve efficiency and safety.
This document provides an overview of Agrobacterium-mediated gene transformation. It begins with an introduction to genetic transformation methods, including direct and indirect techniques. It then discusses Agrobacterium, including its classification, the history of using it for gene transformation, and features of its T-DNA and virulence genes. The document outlines the process of T-DNA transfer from Agrobacterium to plant cells. Finally, it describes some common methods for Agrobacterium-mediated gene transfer, such as infection through wounds, leaf disk, and co-cultivation techniques.
The document summarizes key aspects of culturing cells outside of their native biological environment. Cultured cells experience changes to their microenvironment, cell-cell interactions, and exposure to stimuli. Their growth is influenced by factors like the substrate, medium composition, temperature, and gas phase. Most cells require attachment to a substrate to proliferate. Adhesion molecules like integrins and cadherins mediate attachment and formation of intercellular junctions. The extracellular matrix and cytoskeleton also influence cell behavior. Control of the cell cycle, proliferation, differentiation, motility, and response to the culture environment are described at a high level. Challenges like dedifferentiation and evolution of cell lines over multiple passages are also covered.
Organ culture technique in synthetic media- animal tissue culture neeru02
Organ culture is a development from tissue culture that allows for the culture of pieces of organs on artificial media to accurately model organ functions in various states. Special culture methods are required as organs require high oxygen levels. Organ pieces can be cultured on plasma clots, agar, raft methods using lens paper or rayon, grid methods, or in liquid media using supports like gauze or rafts. Organ culture faces limitations as results may not match whole animal studies due to lack of in vivo drug metabolism.
Gene therapy involves introducing DNA into a patient's cells to treat a disease. There are four main strategies of gene therapy: gene augmentation therapy which adds a functional gene; targeted killing of specific cells like cancer cells; targeted mutation correction; and targeted inhibition of gene expression. Gene therapy shows promise for diseases like cystic fibrosis, hemophilia, cancer and more. Challenges remain around safely delivering genes to the right cells and avoiding immune responses.
The document discusses the production of transgenic organisms. It defines key terms like transgenic, transgene, and transgenesis. It explains that a transgene is a foreign gene deliberately inserted into an organism's genome, making it transgenic. The common methods to produce transgenic animals are pronuclear microinjection and embryonic stem cell methods. The document provides examples of important transgenic animals and their applications in medicine, agriculture, and research.
As opposed to common belief, the measurement of growth in cell culture is fairly simple. Most of the tecchniques that are applied for measurement of microbial growth can be applied to cell culture.Of course with some modification. This presentation exactly explains growth measurement techniques with respect to cell culture. At the end you will also find sample multiple choice questions for practice.
Lectut btn-202-ppt-l25. introduction of dna into host cellsRishabh Jain
This document discusses various methods for introducing DNA into host cells, which is an important step in genetic engineering. It describes transformation, which is introducing DNA into living cells, and transfection, which is introducing viral DNA into living cells. The document then outlines several biological, chemical, and physical methods for transformation and transfection in bacteria, plants, insects, and animal cells. These include techniques like bacterial infection with bacteriophage, Agrobacterium-mediated plant transformation, microprojectile bombardment, electroporation, microinjection, and calcium phosphate transfection. It also discusses factors that affect transformation efficiency.
A gene knockout is a genetic technique in which one of an organism's genes is made inoperative ("knocked out" of the organism). However, gene knockout can also refer to the gene that is knocked out or the organism that carries the gene knockout. Knockout organisms or simply knockouts are used to study gene function, usually by investigating the effect of gene loss. Researchers draw inferences from the difference between the knockout organism and normal individuals.
This document discusses animal biotechnology and methods for sex selection of livestock embryos. It begins by providing context on the history of biotechnology in animal husbandry. Key methods described include artificial insemination, progesterone assays, estrus synchronization, and embryo transfer. Details are given on techniques for sexing embryos, including probes for Y-chromosomes and differences in X-linked enzymes. Challenges to the adoption of these technologies in developing countries are also summarized.
1) The document discusses various cloning technologies including mammalian cloning, reproductive cloning, gene cloning, and therapeutic cloning.
2) Gene cloning involves locating and copying a gene of interest from an organism's DNA. Therapeutic cloning aims to produce patient-matched cells for transplantation through somatic cell nuclear transfer.
3) The benefits of therapeutic cloning discussed include potential alternatives for organ transplantation and treatment of diseases like leukemia and genetic disorders. However, using embryonic stem cells from aborted fetuses is considered morally problematic by some.
Transgenesis is the process of introducing an exogenous gene into an organism to produce a new trait. It allows for more specific, faster, and flexible introduction of traits compared to selective breeding. Golden rice was developed using transgenesis to introduce beta-carotene genes into rice, providing vitamin A. While this could help address vitamin A deficiency, there are also risks like gene transfer and unintended effects that require careful evaluation.
Transfection involves introducing foreign DNA into host cells to produce a new phenotype. There are two main methods of transfection - vector-mediated and non-vector mediated. Vector-mediated transfection uses bacteriophage, retroviral, cosmid, baculovirus, and plasmid vectors to introduce DNA. Non-vector mediated methods include direct techniques like microinjection, electroporation, and particle bombardment, and indirect techniques like calcium phosphate precipitation and DEAE-dextran. Retroviral vectors are modified retroviruses that can introduce foreign DNA into host chromosomal DNA. Microinjection involves injecting DNA directly into cells using a micropipette under a microscope. Electroporation uses electric pulses to create temporary
Types of animal cell culture, characterization and preservationSantosh Kumar Sahoo
Animal cell culture involves growing cells outside their natural environment under controlled conditions. There are two main types of cell culture: primary cell culture which uses cells directly from an animal, and secondary cell culture which uses cell lines that can be propagated repeatedly. Cells may be adherent, attaching to culture surfaces, or in suspension. Characterization of cell lines assesses identity, purity and suitability for use. Cryopreservation allows long-term storage of cells by freezing them at very low temperatures.
Transgenic animals are animals that have had a foreign gene deliberately inserted into their genome using recombinant DNA methodology. The first transgenic mice were created in 1980, and the first cloned mammal, Dolly the sheep, was born in 1996. There are three main methods for creating transgenic animals: DNA microinjection, embryonic stem cell-mediated gene transfer, and retrovirus-mediated gene transfer. Transgenic animals produce useful products like monoclonal antibodies, blood clotting factors, and human milk proteins. They are used for medical research, toxicology studies, pharmaceutical production, and analyzing gene expression regulation. However, some ethical concerns exist regarding animal suffering during transgenic research experiments.
Introduction
Primary Culture
Steps In Primary Culture
Isolation Of Tissue
Dissection And/Or Disaggregation
Types Of Primary Culture
Primary Explant Culture
Enzymatic Disaggregation
Mechanical Disaggregation
Cell Line( Finite & Continuous)
Naming A Cell Line
Choosing A Cell Line
Maintenance Of Cell Line
Conclusion
reference
This is about methods of creating transgenic animals,applications of transgenic animals in biotechnology and application of transgenic animals in pharmaceuticals.
1. Biopharming involves the production of therapeutic proteins through transgenic animals and offers advantages over conventional production methods like lower costs, higher yields, and proper post-translational modifications.
2. The mammary gland is often used for expression since milk can be easily collected and purified. Therapeutic proteins are commonly expressed at grams per liter of milk.
3. While biopharming has promise, challenges remain around low success rates, animal health issues, and concerns about transgene escape into the environment. Ongoing work aims to improve efficiency and safety.
This document provides an overview of Agrobacterium-mediated gene transformation. It begins with an introduction to genetic transformation methods, including direct and indirect techniques. It then discusses Agrobacterium, including its classification, the history of using it for gene transformation, and features of its T-DNA and virulence genes. The document outlines the process of T-DNA transfer from Agrobacterium to plant cells. Finally, it describes some common methods for Agrobacterium-mediated gene transfer, such as infection through wounds, leaf disk, and co-cultivation techniques.
The document summarizes key aspects of culturing cells outside of their native biological environment. Cultured cells experience changes to their microenvironment, cell-cell interactions, and exposure to stimuli. Their growth is influenced by factors like the substrate, medium composition, temperature, and gas phase. Most cells require attachment to a substrate to proliferate. Adhesion molecules like integrins and cadherins mediate attachment and formation of intercellular junctions. The extracellular matrix and cytoskeleton also influence cell behavior. Control of the cell cycle, proliferation, differentiation, motility, and response to the culture environment are described at a high level. Challenges like dedifferentiation and evolution of cell lines over multiple passages are also covered.
Organ culture technique in synthetic media- animal tissue culture neeru02
Organ culture is a development from tissue culture that allows for the culture of pieces of organs on artificial media to accurately model organ functions in various states. Special culture methods are required as organs require high oxygen levels. Organ pieces can be cultured on plasma clots, agar, raft methods using lens paper or rayon, grid methods, or in liquid media using supports like gauze or rafts. Organ culture faces limitations as results may not match whole animal studies due to lack of in vivo drug metabolism.
Gene therapy involves introducing DNA into a patient's cells to treat a disease. There are four main strategies of gene therapy: gene augmentation therapy which adds a functional gene; targeted killing of specific cells like cancer cells; targeted mutation correction; and targeted inhibition of gene expression. Gene therapy shows promise for diseases like cystic fibrosis, hemophilia, cancer and more. Challenges remain around safely delivering genes to the right cells and avoiding immune responses.
The document discusses the production of transgenic organisms. It defines key terms like transgenic, transgene, and transgenesis. It explains that a transgene is a foreign gene deliberately inserted into an organism's genome, making it transgenic. The common methods to produce transgenic animals are pronuclear microinjection and embryonic stem cell methods. The document provides examples of important transgenic animals and their applications in medicine, agriculture, and research.
As opposed to common belief, the measurement of growth in cell culture is fairly simple. Most of the tecchniques that are applied for measurement of microbial growth can be applied to cell culture.Of course with some modification. This presentation exactly explains growth measurement techniques with respect to cell culture. At the end you will also find sample multiple choice questions for practice.
Lectut btn-202-ppt-l25. introduction of dna into host cellsRishabh Jain
This document discusses various methods for introducing DNA into host cells, which is an important step in genetic engineering. It describes transformation, which is introducing DNA into living cells, and transfection, which is introducing viral DNA into living cells. The document then outlines several biological, chemical, and physical methods for transformation and transfection in bacteria, plants, insects, and animal cells. These include techniques like bacterial infection with bacteriophage, Agrobacterium-mediated plant transformation, microprojectile bombardment, electroporation, microinjection, and calcium phosphate transfection. It also discusses factors that affect transformation efficiency.
A gene knockout is a genetic technique in which one of an organism's genes is made inoperative ("knocked out" of the organism). However, gene knockout can also refer to the gene that is knocked out or the organism that carries the gene knockout. Knockout organisms or simply knockouts are used to study gene function, usually by investigating the effect of gene loss. Researchers draw inferences from the difference between the knockout organism and normal individuals.
This document discusses animal biotechnology and methods for sex selection of livestock embryos. It begins by providing context on the history of biotechnology in animal husbandry. Key methods described include artificial insemination, progesterone assays, estrus synchronization, and embryo transfer. Details are given on techniques for sexing embryos, including probes for Y-chromosomes and differences in X-linked enzymes. Challenges to the adoption of these technologies in developing countries are also summarized.
Transgenic sheep were first cloned in 1996 when scientists used somatic cell nuclear transfer to create Dolly the sheep. This involves removing the nucleus of an egg cell and replacing it with the nucleus of a donor adult cell, usually a fibroblast. The reprogrammed cell is then stimulated to divide and develop into an embryo. While transgenic sheep can be useful models for studying various fields like immunology and hematology, the cloning process has low success rates and cloned animals often display abnormalities. Transgenic sheep are also used commercially to produce recombinant proteins in various tissues like milk.
This chapter discusses various methods for creating transgenic animals, including mice, livestock, birds, and fish. DNA microinjection and embryonic stem cell methods are described for generating transgenic mice and other animals. Applications include disease models, bioreactors to produce human proteins in milk, and increasing disease resistance or growth in livestock and fish. The chapter covers transgenic techniques for mice, cattle, sheep, pigs, chickens, and fish.
Objective: To identify interstitial cells of Cajal (ICC) in the common bile duct of Kunming mice.
Study Design: Common bile ducts obtained from the Kunming mice were prepared for immunohistochemical investigations using the c-kit antibody. Immunoelectron microscopy was used to detect the expression of c-kit in the ICC of the common bile duct. Transmission electron microscopy showed ultrastructure of ICC in the murine bile duct. Reverse transcription–polymerase chain reaction (RT-PCR) and western blot were used to confirm the expression of mRNA specific for the c-kit gene and production of c-kit protein in the Kunming mice common bile duct.
Results: Immunohistochemistry revealed that ICC in the murine common bile duct are c-kit positive and the ICC are located in the tela submucosa and the tunica muscularis of the murine common bile duct and do not connect with each other. Immunoelectron microscopy confirmed the expression of Kit by ICC in the murine common bile duct. Transmission electron microscopy showed that ICC in the murine common bile duct have long processes, abundant mitochondria, plenty of smooth endoplasmic reticulum (sER), a lot of lysosomes, and dense bodies. The caveolae of ICC are distinctive. At the same time, RT-PCR indicated that the Kunming mice common bile duct expressed mRNA specific for the c-kit gene, and western blot analysis showed the evidence of production of c-kit protein in the Kunming mice common bile duct.
Conclusion: ICC are found in the Kunming mice common bile duct, which is likely to lead to the development of motility study of the common bile duct.
Keywords: common bile duct; electron microscopy; immuno-electron microscopy; interstitial cells of Cajal; intestines; smooth muscle; tyrosine kinase receptor (c-kit)
This thesis examines the role of the transcription factor Gli3 in regulating neural stem cell proliferation and neuronal fate specification in the subventricular zone (SVZ). The author finds that:
1) Expression of the Gli3 repressor form is higher in dorsal SVZ neural stem cells, while expression of the activator form Gli1 is higher in ventral SVZ stem cells.
2) Conditional ablation of Gli3 in dorsal SVZ stem cells results in their progeny adopting aberrant positions deeper in the olfactory bulb compared to controls.
3) Loss of Gli3 also decreases expression of the dopamine marker TH in dorsal SVZ-derived neurons, making their fate resemble that of ventral
1) Researchers studied a novel method for quantifying and tracking macrophage homing into atherosclerotic plaques using superparamagnetic iron oxide nanoparticles (SPIO).
2) They injected SPIO into ApoE-deficient mice with and without proinflammatory cytokines and found higher iron content and more macrophages in plaques of cytokine-treated mice using histology and mass spectrometry.
3) This demonstrates that SPIO allows both quantitative and qualitative assessment of macrophage infiltration and shows infiltration is enhanced by cytokines, suggesting SPIO-enhanced MRI could noninvasively monitor monocyte recruitment dynamics into plaques over time.
1) Researchers studied a novel method for quantifying and tracking macrophage homing into atherosclerotic plaques using superparamagnetic iron oxide nanoparticles (SPIO).
2) They injected SPIO into ApoE-deficient mice, some of which also received proinflammatory cytokines, and tracked iron uptake in plaques over time.
3) Both quantitative iron assays and staining showed greater iron and macrophage presence in plaques of cytokine-treated mice, demonstrating SPIO can monitor macrophage recruitment influenced by inflammation. This noninvasive MRI-based method may help study monocyte involvement in atherosclerosis.
pOnebyOne™ are efficient, accurate and flexible Bicistronic Mammalian Expression Kits that contains an Expression Cassette based in 2A sequence breakthrough technology.
Its novel (patent pending) technology allows simultaneous Expression of two Proteins from the same mRNA. Cells transfected with Bicistronic vectors ensure that if one of the Proteins is present, the other one is also present.
Bicistronic Expression vectors are supported on viral elements: the IRES or 2A sequence. IRES has been widely used. It is a relative short sequence, around 600-700 bp, although this length could be a disadvantage in viral vectors where packaging capacity is limited. IRES based Expression vectors are characterized by a non-stoichiometric production of both proteins; generally there is a lower expression of the downstream gene.
Many 2A sequences from several families of viruses have been described for producing multiple polypeptides. 2A mediated cleavage is a universal phenomenon in all eukaryotic cells. With just 20 bp in length, the 2A sequence has been used succesfully to generate multiple proteins in some biological models: plants, zebrafish, transgenic mice or eukaryotic cell lines. Vectors based on 2A produce stoichiometric proportion of both proteins.
Canvax™ offers a ready-to-clone solution of your Gene of Interest, obtained by PCR, onto a wide collection of Bicistronic vectors based on 2A sequence. You can choose among different Promoters, selection Antibiotics or Reporter Genes.
This document proposes a non-invasive method using SPIO (super paramagnetic iron oxide) nanoparticles to image macrophage infiltration and inflammation in vulnerable atherosclerotic plaques. Rabbits and mice were injected with SPIO, which accumulated in inflamed plaque areas correlated with macrophage density. SPIO-enhanced MRI then successfully identified these inflamed plaques non-invasively in vivo. This technique could provide a way to detect rupture-prone plaques and better understand plaque vulnerability.
051 plaque inflam detection in atherosclerotic rabbitsSHAPE Society
This document proposes a non-invasive method using SPIO (super paramagnetic iron oxide) nanoparticles to image macrophage infiltration and inflammation in vulnerable atherosclerotic plaques. Rabbits and mice were injected with SPIO, which accumulated in macrophage-rich areas of plaques. MR imaging found SPIO accumulation correlated with macrophage density in plaques. Ex-vivo studies of rabbit aortas also demonstrated SPIO accumulation in inflamed plaques. The authors conclude SPIO-enhanced MRI can non-invasively identify inflamed, vulnerable plaques prone to rupture.
This document proposes a non-invasive method using SPIO (super paramagnetic iron oxide) nanoparticles to image macrophage infiltration and inflammation in vulnerable atherosclerotic plaques. Rabbits and mice were injected with SPIO, which accumulated in inflamed plaque areas correlated with macrophage density. SPIO-enhanced MRI then successfully identified these inflamed plaques non-invasively in vivo. This technique could provide a way to detect rupture-prone plaques and better understand plaque vulnerability.
This document proposes a non-invasive method using SPIO (super paramagnetic iron oxide) nanoparticles to image macrophage infiltration and inflammation in vulnerable atherosclerotic plaques. Rabbits and mice were injected with SPIO, which accumulated in macrophage-rich areas of plaques. MR imaging found SPIO accumulation correlated with macrophage density in plaques. Inflamed plaques in hypercholesterolemic rabbits showed enhanced SPIO signals compared to normal rabbits, demonstrating SPIO-enhanced MRI can identify inflammation in vulnerable plaques.
The Importance Of Animal Uses In AnimalsJessica Lopez
This document discusses using bromophenols as potential therapeutics for treating type 2 diabetes mellitus (T2DM). Bromophenols have been identified as inhibitors of the enzyme tyrosine phosphatase 1B (PTP1B), which is involved in insulin signaling. A series of new bromophenol analogs will be synthesized and tested for PTP1B inhibitory activity using in vitro enzyme assays to elucidate their mechanism of action. Bromophenols occur naturally in marine organisms and have attracted interest as anti-diabetic agents due to their suspected PTP1B inhibitory activity. However, quinone species formed from bromophenols could be toxic, so further study is needed to
This study investigated genetic variations among four sheep breeds related to fecundity and weight gain using microsatellite markers. Blood samples were collected from 40 female sheep from four breeds and were used to extract DNA. Five microsatellites linked to genes for litter size (Fec gene) and fat deposition/weight gain (Ob gene) were selected. Polymerase chain reaction and automated sequencing were used to analyze polymorphisms in the microsatellite markers. Serum was also isolated from blood samples and tested via ELISA to measure levels of LH and leptin hormones. The aim was to analyze the effects of genetic differences among the breeds for two traits: fecundity and weight gain.
The document discusses the need for genetically modified organisms (GMOs) to address challenges in food production. Climate change is expected to make feeding the world population increasingly difficult through impacts like more extreme weather, droughts and storms. This will reduce crop yields further. GMOs could help by developing crops that are resistant to these conditions and produce higher yields. The global population is projected to reach over 9 billion by 2050, requiring more food production. GMOs may offer varieties adapted to different climates and resilient to climate impacts, helping ensure adequate global food supply.
This document discusses using Xenopus laevis frog oocytes as an in vivo system for protein synthesis through mRNA injection. Some key points:
1) Oocytes are well-suited for expressing exogenous proteins from injected mRNA due to stores of enzymes and organelles. mRNA or cDNA can be injected into the cytoplasm or nucleus.
2) X. laevis oocytes are commonly used because the frogs are easy to maintain, oocytes are large and easy to inject, and oocytes can survive outside the body for studies.
3) The two electrode voltage clamp technique is often used to study properties of membrane proteins expressed in oocytes, such as ion channels. Voltage clamping allows measuring current
This study investigated the interaction between estrogen receptors (ERs) and caveolin proteins. HEK 293 cells were transfected with either ERα and caveolin-1 (CAV1) or a mutated ERα where a palmitoylation site was altered. Co-immunoprecipitation and western blotting were performed using antibodies that recognize different ERα epitopes. The results showed co-immunoprecipitation between ERα and CAV1 with both antibodies, and similar co-immunoprecipitation between the mutated ERα and CAV1. This preliminary evidence suggests that palmitoylation of cysteine on ERα may not be required for its interaction with CAV1.
Integrin V can form heterodimers with several subunits to mediate cell-cell and cell-extracellular matrix interactions. During zebrafish gastrulation, V is expressed maternally and zygotically. Here, we used a morpholino-mediated V knockdown strategy to study V function. Although V morphants displayed vascular defects, they also exhibited left-right body asymmetry defects affecting multiple visceral organs. This was preceded by mislocalization of dorsal forerunner cells (DFCs) and malformation of the Kupffer’s vesicle (KV) laterality organ
Transgenic animals and process to make transgenic animalsSnehasishKundu1
The document summarizes topics related to transgenic animals and gene therapy. It discusses transgenic cows, sheep, poultry, and fish. For each animal, it describes the process used to create transgenic versions, including pronuclear microinjection and somatic cell nuclear transfer. Benefits include producing human therapeutic proteins and altering milk composition. Challenges include high costs and low success rates. Gene therapy techniques like viral vectors and electroporation are explained for inserting genes into tissues to treat disease. Somatic gene therapy aims to modify individual patients while germline gene therapy alters heritable genes passed to offspring.
This document provides an overview of the drug discovery and development process. It discusses target identification, where researchers identify biomolecules associated with disease. Target validation then confirms the target's role in the disease. Lead identification involves finding compounds that interact with the target. Leads undergo optimization to improve properties. The methods discussed include high-throughput screening of compound libraries and structure-based drug design. The document also notes the high costs of drug development and increasing innovation deficit in the pharmaceutical industry.
This document discusses the molecular and cellular mechanisms of thyroid hormone and insulin. It describes how thyroid hormones are produced and released by the thyroid gland and how they profoundly influence metabolism. It outlines the steps of thyroid hormone synthesis, including iodide trapping, conversion to iodine, thyroglobulin synthesis, and the coupling reaction. It also discusses insulin synthesis in pancreatic beta cells, the structure of insulin, and its regulation of blood glucose levels.
The document discusses the four levels of structural organization of proteins: primary, secondary, tertiary, and quaternary structure. It describes the primary structure as the linear sequence of amino acids in a protein. Secondary structures form due to hydrogen bonding and include alpha helices and beta sheets. Tertiary structure refers to the three dimensional folding of a protein chain. Quaternary structure occurs when multiple protein chains combine to form a functional protein. The document focuses on different types of secondary structures like alpha helices, beta sheets, loops, and turns.
This document discusses pharmacokinetics and provides details about absorption, distribution, metabolism, and transport processes of drugs in the body. It covers:
1) Absorption is the first process the body undergoes with drugs and is affected by factors like solubility, concentration, surface area, and vascularity. Oral administration is the most common route.
2) Distribution of drugs in the body depends on blood flow, protein binding, and lipophilicity which determines how drugs pass through membranes and tissues.
3) Metabolism primarily occurs in the liver through oxidation reactions catalyzed by cytochrome P450 enzymes, which can activate or inactivate drugs.
Parasympathomimetic and parasympatholytic drugs act on the parasympathetic nervous system. Parasympathomimetics mimic the actions of acetylcholine, activating muscarinic and nicotinic receptors, while parasympatholytics block acetylcholine actions. Examples include pilocarpine and methacholine as parasympathomimetics and atropine as a parasympatholytic. Atropine is a non-selective muscarinic receptor antagonist that causes pupil dilation, decreased secretions, and tachycardia.
This document summarizes a seminar on antisense technology and antisense oligonucleotides. It discusses how antisense technology uses single-stranded oligonucleotides to inhibit gene expression by binding to mRNA and preventing translation into proteins. It also describes how antisense oligonucleotides can be introduced into cells and their mechanisms of action, as well as modifications that can enhance their stability and properties for therapeutic use. The document provides rationale for using antisense technology and examples of antisense drugs in clinical trials.
The document describes several screening models used to evaluate the effects of drugs on behavioral and muscle coordination in animals. It discusses tests such as the open field test, hole board test, chimney test, grip strength, and rota rod method. These tests measure parameters like locomotor activity, exploration, muscle strength, and motor coordination. The results of these tests can provide information about a drug's effects and allow the calculation of values like ED50 doses for sedative, stimulant, and muscle relaxant drugs.
The seminar discussed screening models for central nervous system stimulant and antidepressant drugs. Various in vitro and in vivo models were described for testing CNS stimulants, including assays measuring sand displacement, spontaneous activity in runways, and motor activity detection. Methods for screening antidepressants included assays measuring the inhibition of radiolabeled dopamine, serotonin, or norepinephrine uptake in rat brain synaptosomes. The mechanisms of action and types of antidepressants like tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors were also summarized.
This document discusses various in vitro and in vivo models for screening antipsychotic drugs. It begins by providing background on schizophrenia and antipsychotic drugs. It then describes two important in vitro models - the D1 receptor assay using 3H-SCH 23390 binding and the D2 receptor assay using 3H spiroperidol binding. Both assays are used to determine binding affinity of test compounds to dopamine receptors. Three key in vivo models are also outlined - the open field test to evaluate motor activity, the rota rod test to assess motor coordination, and the grip strength test to measure muscular strength. The document provides details on the procedures and evaluation of these screening models.
The document provides information on sex hormones including:
1. It discusses the history of discoveries related to female reproductive hormones including the establishment of ovarian control and isolation of estrogen.
2. It describes the types of estrogens including natural estrogens like estradiol and synthetic estrogens used orally.
3. It explains progesterone's role in the menstrual cycle and pregnancy, how it is synthesized and secreted, and its physiological actions in various body systems.
Rational drug design involves identifying a biological target related to a disease, determining the target's structure and function, and designing drug molecules that interact with the target in a beneficial way. Key aspects of rational drug design include using computational tools to model protein targets based on their 3D structure, designing drugs that complement the target's active site, and generating new drug leads through database searching and de novo design methods. The goal is to develop effective medications in a time and cost efficient manner by applying knowledge of a drug target's molecular properties.
Dopamine is a neurotransmitter that regulates cardiac, vascular and endocrine function. It is produced in the midbrain and hypothalamus and also functions in the kidneys. Dopamine acts through D1, D2, alpha and beta adrenergic receptors on the cell membrane. It is involved in movement, behavior, prolactin release and other processes through its receptors in areas like the striatum, nucleus accumbens and frontal cortex. Imbalances in dopamine signaling are implicated in disorders such as Parkinson's disease, schizophrenia and substance abuse.
Acetylcholine and adrenaline are important neurotransmitters. Acetylcholine is synthesized from choline and acetyl-CoA by the enzyme choline acetyltransferase. It is stored in vesicles and released into the synapse upon neuronal stimulation. Acetylcholine can bind muscarinic or nicotinic receptors. Muscarinic receptors are G-protein coupled while nicotinic receptors are ligand-gated ion channels. Acetylcholine is broken down by acetylcholinesterase. Adrenaline is synthesized and stored in neurons of the sympathetic nervous system. Upon stimulation, it is released into synapses and binds alpha and beta adrenergic receptors to trigger the "fight or flight"
The document discusses neurotransmission and non-adrenergic, non-cholinergic neurotransmission. It describes how neurotransmitters are synthesized, packaged into vesicles, released into the synaptic cleft upon neuronal stimulation, and bind to receptors on the postsynaptic neuron. It notes that some neurons release multiple neurotransmitters, including glutamate, ATP, nitric oxide, and peptides. The presentation focuses on glutamate as a major excitatory neurotransmitter in the central nervous system that acts through ionotropic AMPA, kainate, and NMDA receptors and metabotropic receptors. Disorders associated with glutamate dysregulation and its role in memory and learning are also mentioned.
The document discusses growth hormone and prolactin. It begins by describing the pituitary gland and its role in controlling other hormone-secreting glands. It then discusses growth hormone, including its structure, secretion, effects on tissues, and disorders related to over- and under-secretion. Growth hormone secretion is stimulated by GHRH and ghrelin. It acts through receptors on tissues to stimulate the JAK-STAT pathway. The document also discusses prolactin, including its structure, regulation of secretion, mechanism of action through the JAK-STAT pathway, and role in breastfeeding.
This document provides an overview of pharmacophore mapping and pharmacophore-based screening. It defines a pharmacophore as the pattern of molecular features responsible for a drug's biological activity. The key steps in pharmacophore modeling are identifying common binding elements in active compounds, generating potential ligand conformations, and determining the 3D relationships between pharmacophore elements. Pharmacophore models can be generated manually based on known active ligands or automatically using software. Receptor-based pharmacophore generation uses the 3D structure of the target protein to identify favorable binding sites. Overall, pharmacophore mapping is used in computer-aided drug design to identify novel ligands that interact with the same biological target.
The document discusses various antiviral agents, including their mechanisms of action, classifications, and pharmacokinetic properties. It focuses on acyclovir, which works by incorporating itself into viral DNA, thereby inhibiting viral replication selectively in infected cells. It also covers zidovudine for HIV, amantadine for influenza by blocking the viral M2 channel, and interferons which induce host enzymes that inhibit viral processes. The antiviral agents discussed work at different stages of the viral life cycle from entry to replication and assembly.
This presentation discusses antifungal agents. It begins by describing fungi and some common fungal infections like candidiasis. It then covers the classification of antifungal agents based on their mechanisms of action and structures. Major antifungal classes discussed include azoles, which inhibit ergosterol synthesis, and polyenes like amphotericin B, which bind to ergosterol in the fungal cell membrane. Specific drugs are described in depth, including their mechanisms, pharmacokinetics, spectra of activity, dosing, and adverse effect profiles. Topical azoles are primarily used for superficial fungal infections, while systemic azoles like ketoconazole and newer triazoles treat both
This document discusses in silico drug design. It begins by defining drugs and the drug design process. Drug molecules should be small, complementary in shape to the target, and oppositely charged. In silico drug design uses computer simulations to identify drug target molecules. There are ligand-based and structure-based approaches. Key steps are selecting a disease and target, target validation, selecting ligands, applying scoring functions, lead optimization, and preclinical/clinical development. The goal is to eliminate compounds that may cause side effects or drug interactions. In silico methods help integrate new technologies with traditional medicinal chemistry experience to discover safe and effective drug leads.
Good Laboratory Practice (GLP) is a formal set of principles that were established by the FDA in 1978 to ensure the quality and integrity of safety testing data submitted for regulatory purposes. GLP provides guidelines for conducting non-clinical laboratory studies, including requirements for facilities, equipment, personnel responsibilities, quality assurance programs, standard operating procedures, and retention of records and reports. The purpose of GLP is to ensure testing is properly conducted and documented so that results are reliable and can be used to support regulatory decisions.
More from B V V S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote (20)
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
How to Setup Warehouse & Location in Odoo 17 InventoryCeline George
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
2. 2
Presented by:- Lingaraj.V.Anawal
M Pharm – 1ST SEM
Department of Pharmacology
H S K College of Pharmacy B.G.K
TRANSGENIC
ANIMALS
08-Apr-20 08:02 PM
4. INTRODUCTION:-
THE FIRST TRANSGENIC ANIMAL?
IN 1966 TEH PING LIN(Dept of Anatomy) AT THE
UNIVERSITY OF CALIFORNIA SCHOOL OF
MEDICINE, SAN FRANCISCO, SHOWED THAT
MOUSE EGGS CAN SURVIVE HAVING A SMALL
QUANTITIES OF LIQUID INJECTED INTO THEM
WITH FINE GLASS NEEDLE. (ARTICLE:- Microinjection
of mouse eggs Published in Science by AAAS on 21st Jan 1996
vol.151 PP=333-337)
IN 1974 RUDOLF JAENISCH(PROFESSOR) AT
THE STALK INSTITUTE AND BEATRICE
MINTZ(AMERCIAN EMBRYOLOGIST) AT THE
FOX CHASE CANCER CENTRE IN
PHILADELPHIA USED THESE METHODS TO
MAKE THE FIRST “TRANSGENIC MOUSE”
408-Apr-20 08:02 PM
6. THEY INJECTED PURIFIED DNA FROM A
SIMIAN VIRUS (SV40) INTO ITS MOUSE
BLASTOCYST.
WHEN THE RESULTING MICE WERE RAISED
TO ADULTHOOD (SV40) DNA IS DETECTED
IN THEIR TISSUES, SUGGESTING THAT THE
INJECTED DNA HAD INTEGRATED INTO
THEIR GENOME.
IN 1980 JON GORDON AND FRANK RUDLE
AT YALE UNIVERSITY INTRODUCED A
CLONED GENE INTO FERTILIZED MOUSE
EGGS VIA MICROINJECTION AND
SHOWED STABLE INTEGRATION OF THE
INJECTED GENE INTO SOMATIC CELLS.
608-Apr-20 08:02 PM
7. BUT WITHIN A YEAR THIS TECHNIQUE PROVED
THAT TRANSGENE NOT ONLY INTEGRATE INTO
THE HOSTS GENOME, BUT ALSO ARE EXPRESSED
AND PASSED ON TO OFFSPRINGS THROUGH
GERM CELLS.
“MICE BECOME THE WORLD’S FIRST
TRANSGENIC ANIMAL”
BUT IT TOOK ANOTHER EIGHT(8) YEARS BEFORE
TRANSGENIC MICE WERE DEVELOPED THAT
PASSED THE TRANSGENE TO THEIR OFFSPRING.
GENETICALLY MODIFIED MICE WERE CREATED IN
1984 THAT CARRIED CLONED ONCOGENES.
THE FIRST ANIMAL TO SYNTHESIZE TRANSGENIC
PROTEIN IN THEIR MILK WERE MICE IN 1987.
708-Apr-20 08:02 PM
8. KNOCKOUT ANIMAL
THESE ARE THE ANIMALS IN WHICH A
SPECIFIC GENE HAS BEEN INACTIVATED
OR KNOCKED OUT BY REPLACING
EXISTING GENE OR BY INTRODUCTION OF
A FOREIGN DNA SEQUENCE.
EXAMPLE:-MOUSE(Mus musculus)
THE FIRST RECORDED KNOCKOUT MICE
WERE CREATED IN 1989 BY MARIO
RAMBERG CAPECCHI, MARTIN EVANS, AND
OLIVER SMITHIES.(BY TURNING OFF
SPECIFIC GENE)
IN 2007 THEY WERE AWARDED NOBEL
PRIZE IN PHYSIOLOGY OR MEDICINE.
808-Apr-20 08:02 PM
11. DEFINITION OF TRANSGENIC
ANIMAL:-
‘Transgenic animal is one whose genome has
been altered by the transfer of gene or genes
from another species or breed’
OR
‘Transgenic animal is one that carries a foreign
gene that has been deliberately inserted into its
genome’
OR
‘Transgenic animals is one containing
recombinant DNA molecules in its genome that
were introduced by intentional human
intervention’
1108-Apr-20 08:02 PM
13. PRODUCTION OF TRANGENIC
ANIMALS
Transgenic animals can be produced by
following methods:-
DNA Microinjection/Pronuclear
Microinjection.
Retrovirus – Mediated Gene Transfer.
Embryonic Stem Cell-Mediated Gene
Transfer.
Electroporation/Electrotransfer.
1308-Apr-20 08:02 PM
14. DNA Microinjection or
Pronuclear Microinjection.
Definition:-
Microinjection is a technique of delivering
foreign DNA into a living cell (a cell, egg,
embroy of animals) through a glass
micropipette.
Microinjection (gene transfer) is most frequently
& commonly used technique for production of
transgenic animals.
1408-Apr-20 08:02 PM
16. PRODUCTION OF TRANSGENIC ANIMAL
Young virgin female mice(4-5 weeks age)
superovulation
Injecting of Pregnant mare’s serum(F.S.H)
2days later(48hr’s)
Injecting of Human Chorionic Gonadotropine
Hormone (H.C.G.H)
30-35 eggs produced (instead of 5-10 eggs)
Mated with male mice (female is sacrificed after 22hrs)
Oviducts are removed into buffer solution.
Oviducts are dissected to release fertilized eggs.
1608-Apr-20 08:02 PM
17. Eggs are washed & kept at 37°C in culture media.
Eggs are observed under dissecting microscope to
distinguish two pronuclei.(male&female)
1.2 PL of buffer containing cloned plasmid DNA is
injected into male pronuclei (microinjection needle)
Eggs with transgene kept overnight in incubator OR
culture media to develop.
Eggs are implanted micro-surgically into oviduct of
Pseudo pregnant female mice(Foster mother).
1708-Apr-20 08:02 PM
18. Pseudo pregnant female mice(Foster mother) deliver
pups after 3 weeks of implantation.
For identification of transgenic animals DNA from
small piece of tail can be assayed by southern blot
Hybridization(Tail blot) / PCR.
1808-Apr-20 08:02 PM
19. TRANSGENIC ANIMALS
Less than 5% of
the Microinjected
Fertilized eggs
Become transgenic
progeny.
In this method none of the steps will give 100% efficient for any animal to
develop into transgenic animal.
In case of mouse of 100% injected only 60-70% of fertilized eggs will
Survive by microinjection procedure, same of about 60-70% of them
implanted into recipient mother(foster mother) to develop into pups, and
only <20% of them are live born & only <5% are transgenic progeny.
Among 1000 fertilized eggs only 30-50 transgenic pups may be
produced (3%-5%).
1908-Apr-20 08:02 PM
22. RETRO VIRUES MEDIATED GENE TRANSFER.
OR
RETROVIRAL VECTOR METHOD.
A retrovirus is a virus that carries its genetic
material in the form of RNA rather than DNA.
Retrovirus used as vectors to transfer genetic
material into the host cell, resulting in a chimera.
This can be best be done at 4-16 cells stage
embryos.
2208-Apr-20 08:02 PM
24. Method of Production:-
Gene of interest is isolated using Restriction
Enzyme.
Vector is a strand of RNA from a retrovirus &
Vector is isolated & cut from the Restriction
Enzyme.
Target gene is inserted into the vector using DNA
Ligase.
The retrovirus contain nucleic acids from
different organism.
2408-Apr-20 08:02 PM
25. Then retrovirus is injected into pre-embryo
(8-cell embryo)
Retrovirus containing pre-embryo are returned to
recipient Pseudo pregnant and allow to develop.
2508-Apr-20 08:02 PM
28. Embryonic Stem Cell-Mediated Gene
Transfer
Embryonic-steam cell mediated gene transfer is
one of the method which involve the introduction
of gene into the embryonic steam cells
(ES cells).
2808-Apr-20 08:02 PM
29. PRODUCTION
Transgenic animals can be created by
manipulating embryonic stem cells.
ES cells are obtained from the inner cell
mass of blastocyst.
Transgene is incorporated in the ES cells by:-
By Microinjection.
By Retrovirus.
By Electroporation/Electropermeabilization.
• Transgenic stem cells are grown in vitro.
• Then they are inserted into a blastocyst and
implanted into a hosts uterus to grow
normally.
2908-Apr-20 08:02 PM
37. IDENTIFICATION OF TARGET GENE IN
TRANSGENIC ANIMALS.
Transgenic animals are identified by:-
PCR (POLYMERASE CHAIN REACTION)
Technique.
Southern Blotting.
PCR:- PCR is laboratory technique which is widely used
to make multiple copies of a segment of DNA.
It is very precise and can be used to amplify or copy a
specific DNA target from a mixture of DNA molecule.
SOUTHERN BLOTTING:- It is one of the method or
procedure which is used to identify/detect a specific
DNA sequence in DNA samples.
3708-Apr-20 08:02 PM
38. Extraction of gene from Transgenic
Animal.
Remove & Digest 0.5-2mm of mouse tail in a polypropylene
centrifuge tube containing 300-500µL(0.3-0.5mL) of DNA
digestion buffer with 0.4-0.5mg of Proteinase K(PK)/ml of
digestion buffer in a 1.5ml in a polypropylene tube.
Incubate at 50-55°C overnight with gently shaking
(mechanical agitation)
Add 0.7-1ml of 100% of ethanol
OR
Neutralized phenol/chloroform/iso-amyl alcohol(25:24:1)
3808-Apr-20 08:02 PM
39. Centrifuge at top speed for 5 min or 16000xg for 30 min.
pour/remove out ethanol.
Wash out DNA pellets by adding 1ml 70% of ethanol
into the tubes & then Re-centrifuge at a top speed for
5min.
Pour out ethanol from the tubes, immediately dissolve
those DNA pellets with 100-300µl TE-buffer solution
without air drying. (TE=Tris&EDTA)
Place the tubes for at 55-60°C for approximately 2hrs
with lids open to let the extra ethanol to evaporate.
The store the DNA sample at 4°C to -20°
39
[DNA Digestion buffer = EDTA + Nacl + Tris + Sodium dodecyl sulfate(SDS)]
08-Apr-20 08:02 PM
40. PCR TECHNIQUE AND REQUIREMENTS
The PCR is carried out in in vitro.
It utilizes :- DNA preparation containing the desired
segment of DNA to be amplified.
Two nucleotide primers of specific to 3’ borders.
Four deoxynucleoside triphosphates:-
(a)TTP(thymidine triphosphate)
(b)dCTP(deoxycyctidine triphosphate)
(c)dATP(deoxyadenosine triphosphate)
(d)dGTP(deoxyguanosine triphosphate)
Heat stable DNA polymerase:-
(a)Taq(isolated from bacterium thermus
acquaticus)
(b)Pfu(Pyococcus furiosus)
(c)Vent(Thermococcus litoralis)
4008-Apr-20 08:02 PM
48. Eg:-TRANSGENIC ANIMALS
DOLLY(female domestic sheep)
Dolly is a 1st mammal cloned from an adult somatic cell
using the process of nuclear transfer.
Experiment is carried out by Sir Ian Wilmut, Keith Campbell
& colleagues at the Roslin institute in collaboration with
biotechnology company PPL therapeutics in Edinburgh
Scotland.
48
DOLLY
08-Apr-20 08:02 PM
50. SUPERMICE OR GAINT MICE
In 1982 Ralph Lawrence Brinster & Colleagues at
the university of Pennsylvania school of veterinary
medicine successfully injected the gene encoding
rat GH into mouse embryo.
50
SUPERMICE or
GAINT MICE
08-Apr-20 08:02 PM
51. PRODUCTION OF BIOSTEEL(High strength
fiber-based material)
Montreal based Nexia Biotechnology Company in Canada
implanted a single spider (Genus=Araneus) gene into the egg
cells of lactating Nigerian Dwarf Goat. Their cloning led to the
birth of the first ‘silk milk goat’
51
SILK MILK GOAT
08-Apr-20 08:02 PM
52. ORNAMENTAL FISH PRODUCTION
The Glofish was common zebra (Danio rerio)
aquarium fish which was fluorescent red in color due
to the insertion of red fluorescent sea coral gene.
52
SEA CORAL ZEBRA AQUERIUM FISH
08-Apr-20 08:02 PM
55. APPLICATION
Industrial importance:-
Toxicity sensitive transgenic animals to test
chemicals.
Spider silk in milk of goat.
For Pharmaceutical testing and development.
As bioreactors to produce pharmacologically
important proteins.
Medical importance:-
Disease model.
Xenotransplantation. /Xenografting
Bioreactor for pharmaceutical.
5508-Apr-20 08:02 PM
56. Agricultural importance:-
Disease resistance animals.
For improving quality and quantity of milk, meat,
eggs, and wool production etc…
Biological function of specific genes.
To develop animal model for disease
of humans or animals.
To produce therapeutic products,
and vaccines.
Biological screening etc…
Vaccine safety e.g.:- polio vaccine
5608-Apr-20 08:02 PM
57. CONCLUSION
Transgenic Technology is a field that is under
constant evolution.
Transgenic animals are now-a-days used for
screening of many drugs.
Transgenic animals reduce number of
experimental animals during testing.
Many of transgenic animals have been
successfully created for a variety of purposes
and prospects are enormous.
It also hold a great potential in many field
including agriculture, medicine, and industry.
5708-Apr-20 08:02 PM
58. With a proper research and careful use the
transgenic animals can go a long way in solving
several problems for which science doesn’t have
a solution till now.
5808-Apr-20 08:02 PM
59. REFERENCE:-
Screening Methods in Pharmacology N.S.Parmar
Shiva Prakash Narsosa Publishing House.
Molecular Biotechnology (Principles and Applications of
Recombinant DNA) by Bernard R. Glick and Jack J.
Pasternak-2nd Edition.
DNA Science A FIRST COARSE 2nd edition by DAVID A.
MICKLOS,GREG A. FREYER WITH DAVID A. CROTTY.
i Genetics A Molecular Approach by Peter J. Russell 2nd
edition(IE)
https://www.future-science.com/doi/full/10.2144/000112255
https://www.jax.org/jax-mice-and-services/customer-
support/technical-support/genotyping-resources/dna-
isolation-protocols
5908-Apr-20 08:02 PM